跳至主要内容
临床试验/TCTR20230320008
TCTR20230320008
已完成
不适用

iver injury in mild COVID-19 with various COVID pandemic phases, a real-world study.

avamindradhiraj University Research Fund0 个研究点目标入组 300 人2023年3月20日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
To evaluate in the proportion of patients with COVID-19 infection and hospitalized in the hospital, hospital field, and cohort ward with liver injury due to a variety of real-world anti-COVID-19 medications and other consequences of COVID-19 infection.
发起方
avamindradhiraj University Research Fund
入组人数
300
状态
已完成
最后更新
去年

概览

简要总结

We report more than a third of the cases are associated with mild liver injuries. Even liver-specific of ALT, our report a greater AST than ALT.Several patients with liver damage had modest baseline transaminitis; nevertheless, this was not a barrier to initiating medication.Only four (14.8%) of the previous liver disease had baseline compensated cirrhosis, and none had significant transaminitis.

注册库
who.int
开始日期
2023年3月20日
结束日期
2022年10月31日
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
avamindradhiraj University Research Fund

入排标准

入选标准

  • Eligible individuals were inpatients age \>18 years, who were admitted to the hospitel, hospital field, and cohort ward after RT\-PCR testing confirmed the diagnosis of COVID\-19 infection. For hospitel and hospital fields, symptomatic COVID\-19 without pneumonia, and absence of risk factors for severe disease are inclusion criteria. Any of the following cohort wards qualify for symptomatic COVID\-19 treatment: having severe illness risk factors or with mild pneumonia.

排除标准

  • 1\.Patients with pneumonia and hypoxia will require an oxygen supplement
  • 2\.Patients with moderate to severe pneumonia (infiltration \> 20% of total lung)
  • 3\.Pregnant or breast\- feeding women.

结局指标

主要结局

未指定

相似试验